check quantity

IL-7 (human) AlphaLISA Detection Kit, 5,000 Assay Points

The AlphaLISA® Human Interleukin 7 (IL7) Detection Kit is designed for detection and quantitation of human IL-7 in serum, buffered solution or cell culture medium in a homogeneous (no-wash steps, no separation steps) assay.

Please enter valid quantity

Please login to add favorites

NULL OR EMPTY CART

Product Number Unit Size List Price Your Price Quantity
AL268C 500 assay points 1433.00 USD
AL268F 5,000 assay points 9500.00 USD

You successfully added item(s) to your cart

Overview

Formats:

  • Our 500 assay point kit allows you to run 500 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).
  • Our 5,000 assay point kit allows you to run 5,000 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).

Features:

  • No-wash steps, no separation steps
  • ELISA alternative technology
  • Sensitive detection
  • Broad sample compatibility
  • Small sample volume
  • Results in less than 3 hours
  • Half the time of an ELISA assay

Human Interleukin 7 (IL7) is produced as a precursor maturing into a 152 amino acid glycoprotein. IL7 is mainly produced by non-hematopoietic cells like stroma cells in the bone marrow, the thymus, and in lymphoid tissues. IL7 acts mainly on stem cells and induces proliferation and differentiation of pre-B cells, thymocytes and T cell progenitors and co-stimulates proliferation of mature T-cells with other factors such as IL2. It also protects thymocytes from apoptosis through an increased expression of bcl2. IL7 increases the growth, the development, and the anti-viral activity of both CD4+ and CD8+ cells. Clinical results suggest that IL7 is a potential candidate in the treatment of HIV-patients. IL7 is also implicated in rheumatoid arthritis, chronic colitis, and asthma.

AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.

Disclaimer: For research use only. Not for use in diagnostic procedures.

Specifications

Assay Target IL7
Assay Target Class Cytokine
Automation Compatible Yes
Detection Method Alpha
Experimental Type In vitro
Product Brand Name AlphaLISA
Shipping Condition Blue Ice
Therapeutic Area Inflammation
Unit Size 5,000 assay points

Resources, Events & More

Resource Type File Name File Format
Data Sheet Manual AlphaLISA Human IL7 AL268 PDF 208 KB